Cite

HARVARD Citation

    Parakh, S. et al. (2019). Real‐world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. Asia-Pacific journal of clinical oncology. 15 (1), pp. 26-30. [Online]. 
  
Back to record